Verisk Analytics, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
| Item 5. | Other Information |
|---|
Rule10b5-1 and Non-Rule10b5-1 Trading Arrangements
During the fiscal quarter ended* September 30, 2026*, the following Section16 officers and directors adopted, modified or terminated a “Rule10b5-1 trading arrangement” (as defined in Item408 of Regulation S-K):
| ● | Bruce Hansen, Independent Chair of the Board of Directors, adopted a new trading plan on July 31, 2026 (with the first trade under the new plan scheduled for a date on or after January 15, 2027). The trading plan will be effective until March 31, 2027, to sell up to 5,103 shares of common stock. |
| ● | Kathlyn Card Beckles, Executive Vice President and Chief Legal Officer, adopted a new trading plan on July 31, 2026 (with the first trade under the new plan scheduled for a date on or after January 20, 2027). The trading plan will be effective until April 1, 2027, to sell up to 4,919 shares of common stock. |
There wereno “non-Rule10b5-1 trading arrangements” (as defined in Item408 of Regulation S-K) adopted, modified or terminated during the fiscal quarter ended* September 30, 2026* by Section16 officers and directors. Each of the Rule10b5-1 trading arrangements is in accordance with our Insider Trading Policy and actual sale transactions made pursuant to such trading arrangements will be disclosed publicly in Section16 filings with the SEC in accordance with applicable securities laws, rules and regulations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.